RAPT Therapeutics
RAPT Therapeutics is a Healthcare & Life Sciences startup based in South San Francisco, the United States, most recent round Pre-IPO, 1 tracked investor.
About RAPT Therapeutics
RAPT Therapeutics is a company headquartered in South San Francisco, the United States. Its most recent tracked round is Pre-IPO. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
RAPT Therapeutics is a clinical-stage immunology-focused biopharmaceutical company developing novel therapies, including a half-life extended monoclonal antibody targeting free IgE, to treat inflammatory, immunologic, and allergic diseases such as food allergies and chronic spontaneous urticaria.
Explore RAPT Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.